XNAS 01 May, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Peter DeMuth | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 41,600 | 41,600 | - | - | Stock Option (Right to Buy) | |
| Peter DeMuth | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 20,800 | 21,543 | - | 0 | Common Stock | |
| Preetam Shah | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 24,000 | 24,000 | - | 0 | Common Stock | |
| Preetam Shah | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 47,900 | 47,900 | - | - | Stock Option (Right to Buy) | |
| Robert Connelly | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 147,200 | 147,200 | - | - | Stock Option (Right to Buy) | |
| Robert Connelly | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 73,600 | 120,570 | - | 0 | Common Stock | |
| Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 50,900 | 50,900 | - | - | Stock Option (Right to Buy) | |
| Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 25,400 | 57,381 | - | 0 | Common Stock | |
| Peter DeMuth | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.41 per share. | 09 Dec 2025 | 362 | 743 | - | 4.4 | 1,596 | Common Stock |
| Peter DeMuth | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 362 | 0 | - | - | Stock Option (Right to Buy) | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,225 | 103,225 | - | - | Warrant (right to buy) | |
| Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Robert R. Ruffolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Karen J. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Jay R. Venkatesan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Carol Gail Ashe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Preetam Shah | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 191,624 | 191,624 | - | - | Stock Option (Right to Buy) | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | 05 Mar 2025 | 3,442,341 | 0 | - | - | Convertible Note (convertible into Common Stock) | ||
| Yekaterina Chudnovsky | Director, Ten Percent Owner | 05 Mar 2025 | 3,500,573 | 5,416,212 | - | 5.8 | 20,338,329 | Common Stock | |
| Peter DeMuth | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 44,400 | 44,400 | - | - | Stock Option (Right to Buy) | |
| Robert Connelly | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 121,600 | 121,600 | - | - | Stock Option (Right to Buy) | |
| Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Peter DeMuth | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 381 | 0 | - | - | Stock Option (Right to Buy) | |
| Peter DeMuth | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.41 per share. | 16 Dec 2024 | 381 | 381 | - | 4.4 | 1,680 | Common Stock |
| Jay R. Venkatesan | Director | 26 Nov 2024 | 50,000 | 0 | - | - | Warrant to Purchase Common Stock | ||
| Jay R. Venkatesan | Director | 26 Nov 2024 | 50,000 | 179,581 | - | 0.0 | 500 | Common Stock | |
| Jay R. Venkatesan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Carol Gail Ashe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Karen J. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Robert R. Ruffolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Peter DeMuth | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 29,800 | 29,800 | - | - | Stock Option (Right to Buy) | |
| Robert Connelly | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 91,600 | 91,600 | - | - | Stock Option (Right to Buy) | |
| Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 28,200 | 28,200 | - | - | Stock Option (Right to Buy) | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Aug 2024 | 3,442,341 | 3,442,341 | - | - | Convertible Note (convertible into Common Stock) | |
| Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 1,600,000 | 1,600,000 | - | - | Pre-Funded Warrants | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 1,600,000 | 1,600,000 | - | - | Common Warrants | |
| Jay R. Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Jay R. Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Mar 2024 | 1,032,702 | 1,032,702 | - | - | Pre-Funded Common Stock Purchase Warrant | |
| DeMuth Peter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 29,800 | 29,800 | - | - | Stock Option (right to buy) | |
| Piekos Brian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 43,225 | 43,225 | - | - | Stock Option (right to buy) | |
| Haqq Christopher | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 28,200 | 28,200 | - | - | Stock Option (right to buy) | |
| Peter DeMuth | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 342 | 342 | - | - | Stock Option (right to buy) | |
| Connelly Robert | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 225,137 | 225,137 | - | - | Stock Option (right to buy) | |
| Adams Julian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Venkatesan Jay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Chudnovsky Yekaterina | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Nissenson Allen R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Ruffolo Robert R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Ashe Carol Gail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.81 per share. | 22 Dec 2023 | 1,213,000 | 1,915,639 | - | 5.8 | 7,047,530 | Common Stock |
| Brian Piekos | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 75,484 | 75,484 | - | - | Stock Option (right to buy) |